Losartan Potassium Tablet, Film Coated
Product Images NDC 42708-055

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 42708-055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (42708 055 30)

This is a description of a medication called Losartan Potassium in tablet form with a dosage of 50mg. The package contains 30 tablets with a lot number and expiration date. The medication is distributed by QPharma, Inc. and should be stored at a controlled room temperature, with the container tightly closed and kept out of reach of children. The dosage is not specified in the text and should be seen in the package insert. Therefore, it is recommended to take '____ tab(s) ___ time(s) daily or every ___hours for ____ days.' This is a prescription medication.*

FDA Label Image

Figure1 (Losartan Fig1)

This appears to be a partial table or graph displaying the adjusted risk reduction percentage for Atenolol and Losartan Potassium over a period of 66 months. The percentage for Atenolol is not given and only the term "p=" is displayed. Therefore, the information provided is not enough to generate a useful description.*

FDA Label Image

Figure2 (Losartan Fig2)

FDA Label Image

Figure 3 (Losartan Fig3)

The text is not readable.*

FDA Label Image

Figure-4 (Losartan Fig4)

This appears to be a table displaying the results of a study comparing the effectiveness of a medication called "Losartan Potassium" versus a placebo. The table shows that out of a certain number of patients, 60% who took Losartan experienced an "event" (it is unclear what this means without more context), while 40% of those who took the placebo experienced the event. The "Risk Reduction" with Losartan is shown to be 16.1% and the p-value of the comparison is 0.022.*

FDA Label Image

Chemical Structure (Losartan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.